187 related articles for article (PubMed ID: 19232422)
1. Chimeric AAV Cap sequences alter gene transduction.
Ward P; Walsh CE
Virology; 2009 Apr; 386(2):237-48. PubMed ID: 19232422
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.
Lochrie MA; Tatsuno GP; Arbetman AE; Jones K; Pater C; Smith PH; McDonnell JW; Zhou SZ; Kachi S; Kachi M; Campochiaro PA; Pierce GF; Colosi P
Virology; 2006 Sep; 353(1):68-82. PubMed ID: 16806384
[TBL] [Abstract][Full Text] [Related]
3. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
Yang L; Li J; Xiao X
Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
[TBL] [Abstract][Full Text] [Related]
5. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR
Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326
[TBL] [Abstract][Full Text] [Related]
6. Transposon-based mutagenesis generates diverse adeno-associated viral libraries with novel gene delivery properties.
Koerber JT; Schaffer DV
Methods Mol Biol; 2008; 434():161-70. PubMed ID: 18470644
[TBL] [Abstract][Full Text] [Related]
7. Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy.
Michelfelder S; Lee MK; deLima-Hahn E; Wilmes T; Kaul F; Müller O; Kleinschmidt JA; Trepel M
Exp Hematol; 2007 Dec; 35(12):1766-76. PubMed ID: 17920758
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Wu Z; Asokan A; Samulski RJ
Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
[TBL] [Abstract][Full Text] [Related]
9. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
[TBL] [Abstract][Full Text] [Related]
10. Altering AAV tropism with mosaic viral capsids.
Gigout L; Rebollo P; Clement N; Warrington KH; Muzyczka N; Linden RM; Weber T
Mol Ther; 2005 Jun; 11(6):856-65. PubMed ID: 15922956
[TBL] [Abstract][Full Text] [Related]
11. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
[TBL] [Abstract][Full Text] [Related]
12. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
Chadeuf G; Ciron C; Moullier P; Salvetti A
Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
[TBL] [Abstract][Full Text] [Related]
13. Serotype-specific detection of adeno-associated virus during laboratory preparation.
Mitchell DA; O'Donnell J; Hare JT; Chapman MS
J Virol Methods; 2006 Sep; 136(1-2):277-82. PubMed ID: 16815560
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus capsid serotype identification: Analytical methods development and application.
Van Vliet K; Mohiuddin Y; McClung S; Blouin V; Rolling F; Moullier P; Agbandje-McKenna M; Snyder RO
J Virol Methods; 2009 Aug; 159(2):167-77. PubMed ID: 19447508
[TBL] [Abstract][Full Text] [Related]
15. [Capsid assembly and DNA encapsidation of adeno-associated virus].
Wang Q; Lü Y; Li Z; Diao Y; Xu R
Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):531-8. PubMed ID: 21847986
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids.
Grifman M; Trepel M; Speece P; Gilbert LB; Arap W; Pasqualini R; Weitzman MD
Mol Ther; 2001 Jun; 3(6):964-75. PubMed ID: 11407911
[TBL] [Abstract][Full Text] [Related]
17. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
[TBL] [Abstract][Full Text] [Related]
18. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus.
Rabinowitz JE; Xiao W; Samulski RJ
Virology; 1999 Dec; 265(2):274-85. PubMed ID: 10600599
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in adeno-associated virus vector technology.
Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
